1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Bradykinin receptor antagonists are at the forefront of innovative therapeutic solutions, propelled by advances in biologics, precision medicine, and supply chain resilience. This market is shaped by evolving clinical needs, ongoing regulatory adjustments, and targeted strategies for sustainable growth.
Market Snapshot: Bradykinin Receptor Antagonist Market
The bradykinin receptor antagonist market is experiencing robust transformation, with a dynamic growth trajectory influenced by scientific breakthroughs and expanding therapeutic applications. High R&D investment, streamlined drug design, and scalable production underpin ongoing sector development. Market activity intensifies in regions offering mature regulatory frameworks and efficient clinical trial infrastructure, driving the sector’s overall momentum.
Scope & Segmentation
- Therapeutic Types: Biologics (including monoclonal antibodies and peptide-based compounds) and small molecule antagonists.
- Indications: Chronic cough, diabetic nephropathy, and hereditary angioedema, further categorized into acute attack and prophylaxis as appropriate.
- Administration Routes: Inhalation, oral (capsules and tablets), parenteral (IV and subcutaneous), and topical options.
- Distribution Channels: Hospital pharmacy (inpatient and outpatient), online pharmacy (direct to patient, pharmacy pickup), and retail pharmacy (chain and independent outlets).
- End Users: Ambulatory care clinics, diagnostic centers, home nursing, self-administration models, and private and public hospitals.
- Regions: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and additional markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and more).
- Key Companies: Leading participants include Takeda Pharmaceutical Company Limited, BioCryst Pharmaceuticals, Pharvaris ApS, CSL Limited, Pharming Group N.V., Swedish Orphan Biovitrum AB, KalVista Pharmaceuticals, Ionis Pharmaceuticals, Merck & Co., and Pfizer.
Key Takeaways for Senior Decision-Makers
- Innovative drug design, enabled by advances in structural biology and high-throughput synthesis, is streamlining the discovery and optimization of bradykinin receptor antagonists.
- Expanding therapeutic indications—beyond hereditary angioedema to areas such as chronic cough and diabetic nephropathy— are guiding diversified clinical development and strategic investment.
- Precision medicine and biomarker-driven approaches enhance patient selection and response monitoring, offering market differentiation and tighter control over treatment outcomes.
- Collaborative alliances across academia and industry, including partnerships with contract research organizations, accelerate pipeline progression and risk-sharing in new molecule development.
- Advances in manufacturing, such as continuous processing and digital health integration, improve quality, scalability, and post-launch patient monitoring.
Tariff Impact and Strategic Response
- 2025 United States tariffs have raised costs across supply chains for bradykinin receptor antagonists, particularly impacting peptide and antibody raw materials.
- Firms are reexamining sourcing strategies, investing in regional production, and renegotiating long-term supply contracts to mitigate exposure to price volatility and logistics disruptions.
- Process optimization, vertical integration, and adoption of continuous manufacturing practices are key strategies supporting operational resilience and margin preservation.
Methodology & Data Sources
This report applies a mixed-methodology approach, combining primary interviews with industry leaders, clinical researchers, and executives, alongside analysis of regulatory filings, peer-reviewed literature, proprietary datasets, and real-time supply chain developments. Analytical rigor includes cross-source validation, thematic coding, and multi-stage quality control to ensure robust, up-to-date insights.
Why This Report Matters
- Enables informed strategy by mapping the latest innovations, pipeline priorities, and regulatory developments affecting bradykinin receptor antagonists.
- Supports operational risk mitigation through thorough assessment of supply chain, tariff impact, and procurement dynamics.
- Delivers actionable segmentation and regional coverage, helping leaders align investment, market access, and partnership strategies to emerging clinical opportunities.
Conclusion
The bradykinin receptor antagonist market is rapidly evolving, driven by scientific innovation, adaptive trial designs, and resilient supply models. Leaders equipped with this report’s insights can anticipate trends, make data-driven decisions, and navigate the complexities of an increasingly competitive global landscape.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in non-peptide small molecule B2 receptor antagonists with improved oral bioavailability for chronic angioedema therapy
5.2. Strategic collaborations between leading biotechs and pharmaceutical companies on bradykinin receptor antagonist pipeline expansion in inflammatory diseases
5.3. Development of dual-action B1/B2 bradykinin receptor antagonists targeting neuropathic pain and inflammatory biomarkers in clinical trials
5.4. Regulatory milestone achievement for first-in-class kinin B1 receptor small molecule antagonist receiving FDA fast track designation
5.5. Innovative inhalation-based delivery platforms for bradykinin B2 receptor antagonists in acute respiratory distress syndrome management
5.6. Increased patent filings and IP litigation around novel bradykinin receptor antagonist scaffolds focused on improved receptor selectivity
5.7. Emerging evidence on bradykinin receptor antagonists reducing COVID-19 induced pulmonary complications in critical care settings
5.8. Integration of computational modeling and AI-driven drug design to identify new bradykinin receptor antagonist leads with optimized pharmacodynamics
5.2. Strategic collaborations between leading biotechs and pharmaceutical companies on bradykinin receptor antagonist pipeline expansion in inflammatory diseases
5.3. Development of dual-action B1/B2 bradykinin receptor antagonists targeting neuropathic pain and inflammatory biomarkers in clinical trials
5.4. Regulatory milestone achievement for first-in-class kinin B1 receptor small molecule antagonist receiving FDA fast track designation
5.5. Innovative inhalation-based delivery platforms for bradykinin B2 receptor antagonists in acute respiratory distress syndrome management
5.6. Increased patent filings and IP litigation around novel bradykinin receptor antagonist scaffolds focused on improved receptor selectivity
5.7. Emerging evidence on bradykinin receptor antagonists reducing COVID-19 induced pulmonary complications in critical care settings
5.8. Integration of computational modeling and AI-driven drug design to identify new bradykinin receptor antagonist leads with optimized pharmacodynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Bradykinin Receptor Antagonists Market, by Type
8.1. Introduction
8.2. Biologic
8.2.1. MAb
8.2.2. Peptide
8.3. Small Molecule
8.2. Biologic
8.2.1. MAb
8.2.2. Peptide
8.3. Small Molecule
9. Bradykinin Receptor Antagonists Market, by Indication
9.1. Introduction
9.2. Chronic Cough
9.2.1. Idiopathic Cough
9.2.2. Refractory Cough
9.3. Diabetic Nephropathy
9.4. Hereditary Angioedema
9.4.1. Acute Attack
9.4.2. Prophylaxis
9.2. Chronic Cough
9.2.1. Idiopathic Cough
9.2.2. Refractory Cough
9.3. Diabetic Nephropathy
9.4. Hereditary Angioedema
9.4.1. Acute Attack
9.4.2. Prophylaxis
10. Bradykinin Receptor Antagonists Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Oral
10.3.1. Capsule
10.3.2. Tablet
10.4. Parenteral
10.4.1. IV
10.4.2. SC
10.5. Topical
10.2. Inhalation
10.3. Oral
10.3.1. Capsule
10.3.2. Tablet
10.4. Parenteral
10.4.1. IV
10.4.2. SC
10.5. Topical
11. Bradykinin Receptor Antagonists Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Inpatient
11.2.2. Outpatient
11.3. Online Pharmacy
11.3.1. Direct To Patient
11.3.2. Pharmacy Pickup
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
11.2. Hospital Pharmacy
11.2.1. Inpatient
11.2.2. Outpatient
11.3. Online Pharmacy
11.3.1. Direct To Patient
11.3.2. Pharmacy Pickup
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. Bradykinin Receptor Antagonists Market, by End User
12.1. Introduction
12.2. Ambulatory Care
12.2.1. Clinics
12.2.2. Diagnostic Centers
12.3. Home Care
12.3.1. Home Nursing
12.3.2. Self Administration
12.4. Hospital
12.4.1. Private Hospital
12.4.2. Public Hospital
12.2. Ambulatory Care
12.2.1. Clinics
12.2.2. Diagnostic Centers
12.3. Home Care
12.3.1. Home Nursing
12.3.2. Self Administration
12.4. Hospital
12.4.1. Private Hospital
12.4.2. Public Hospital
13. Americas Bradykinin Receptor Antagonists Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bradykinin Receptor Antagonists Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bradykinin Receptor Antagonists Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Takeda Pharmaceutical Company Limited
16.3.2. BioCryst Pharmaceuticals, Inc.
16.3.3. Pharvaris ApS
16.3.4. CSL Limited
16.3.5. Pharming Group N.V.
16.3.6. Swedish Orphan Biovitrum AB
16.3.7. KalVista Pharmaceuticals, Inc.
16.3.8. Ionis Pharmaceuticals, Inc.
16.3.9. Merck & Co., Inc.
16.3.10. Pfizer Inc.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Takeda Pharmaceutical Company Limited
16.3.2. BioCryst Pharmaceuticals, Inc.
16.3.3. Pharvaris ApS
16.3.4. CSL Limited
16.3.5. Pharming Group N.V.
16.3.6. Swedish Orphan Biovitrum AB
16.3.7. KalVista Pharmaceuticals, Inc.
16.3.8. Ionis Pharmaceuticals, Inc.
16.3.9. Merck & Co., Inc.
16.3.10. Pfizer Inc.
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRADYKININ RECEPTOR ANTAGONISTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRADYKININ RECEPTOR ANTAGONISTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRADYKININ RECEPTOR ANTAGONISTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHAI
FIGURE 26. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHSTATISTICS
FIGURE 27. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHCONTACTS
FIGURE 28. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRADYKININ RECEPTOR ANTAGONISTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRADYKININ RECEPTOR ANTAGONISTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHAI
FIGURE 26. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHSTATISTICS
FIGURE 27. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHCONTACTS
FIGURE 28. BRADYKININ RECEPTOR ANTAGONISTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRADYKININ RECEPTOR ANTAGONISTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY MAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY MAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IDIOPATHIC COUGH, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IDIOPATHIC COUGH, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REFRACTORY COUGH, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REFRACTORY COUGH, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ACUTE ATTACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ACUTE ATTACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PHARMACY PICKUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PHARMACY PICKUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME NURSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME NURSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 183. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 186. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 187. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 190. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 191. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 192. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 193. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 196. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 197. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 198. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 199. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 210. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 211. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 212. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 213. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 214. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 246. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MIL
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY MAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY MAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IDIOPATHIC COUGH, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IDIOPATHIC COUGH, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REFRACTORY COUGH, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY REFRACTORY COUGH, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ACUTE ATTACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ACUTE ATTACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PHARMACY PICKUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PHARMACY PICKUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME NURSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME NURSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 183. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 186. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 187. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 190. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 191. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 192. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 193. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 196. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 197. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 198. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 199. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 210. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 211. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 212. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 213. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 214. CANADA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 246. MEXICO BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY BIOLOGIC, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY CHRONIC COUGH, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA BRADYKININ RECEPTOR ANTAGONISTS MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MIL
Samples
LOADING...
Companies Mentioned
The companies profiled in this Bradykinin Receptor Antagonists market report include:- Takeda Pharmaceutical Company Limited
- BioCryst Pharmaceuticals, Inc.
- Pharvaris ApS
- CSL Limited
- Pharming Group N.V.
- Swedish Orphan Biovitrum AB
- KalVista Pharmaceuticals, Inc.
- Ionis Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Pfizer Inc.
